Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Cutting-Edge Transbronchial Aspiration Needle to Revolutionize Minimally Invasive Diagnostic Techniques

By HospiMedica International staff writers
Posted on 11 Sep 2023

An innovative transbronchial aspiration (TBNA) needle is redefining the norms for accuracy, user-friendliness, and patient comfort, offering healthcare providers an unprecedented tool for obtaining top-quality tissue samples crucial for the reliable diagnosis and staging of lung cancer.

Broncus Medical (San Jose, CA, USA) has unveiled its game-changing BioStar TBNA Needle designed to transform minimally invasive diagnostic procedures, thereby enhancing patient care and clinical outcomes. This cutting-edge needle seamlessly integrates with endobronchial ultrasound bronchoscopy (EBUS) procedures and is compatible with both traditional TBNA (cTBNA) and EBUS-enabled TBNA (EBUS-TBNA) diagnostic methods.

The BioStar TBNA Needle stands out for its superior, ultra-slim design, which minimizes tissue damage, enhances reach, reduces the force needed for puncturing, and improves patient comfort during the sampling process. Equipped with an improved needle design and exceptional ultrasound echogenicity, the device allows clinicians to navigate complex anatomical structures with pinpoint accuracy. Its ergonomically designed handle ensures optimum maneuverability, enabling seamless control and precise needle placement during various medical procedures.

Featuring a Beak-shaped needle tip, the BioStar TBNA Needle enhances sample gathering capabilities and ensures optimal specimen extraction for reliable pathological examination. The needle is available with two tip configurations—standard Slant and Beak-shaped tips. Designed with an easy-to-use interface and straightforward setup, the BioStar TBNA Needle streamlines the procedural routine, which is invaluable in high-paced clinical environments. Available in 21G, 22G, and 25G needle sizes, the 21G BioStar EBUS needle features thin walls, allowing for better access to hard-to-reach nodes while collecting samples like a 19G needle. The BioStar TBNA Needle is now accessible to healthcare professionals in Europe and other global locations, except for the USA, who are looking to enhance their diagnostic capabilities.

"Our commitment to advancing patient care and diagnostic accuracy has driven us to develop the BioStar TBNA Needle – a revolutionary tool that empowers medical professionals to make confident, informed decisions," said Christian Rumpf, PhD, Sr. Director Sales & Marketing Europe.

Related Links:
Broncus Medical 

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Enteral Feeding Pump
SENTINELplus
Xenon Light Source
CLV-S400
Newborn Hearing Screener
ALGO 7i
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.